Prostate Cancer

There is a clear need for improved prostate cancer diagnosis and ProteoMediX will offer an easy applicable diagnostic tool with clear competitive advantages.

ProteoMediX's first diagnostic blood-based test for prostate cancer combines the measurement of 5 different proteins. The first results showed very high specificity and could therefore potentially reduce the number of unnecessary biopsies when compared with current screening methods.